Skip to Main Content
Skip Nav Destination

Brain damage from stroke and traumatic brain injury (TBI) is a leading cause of death and disability, but the existing therapeutic options are limited, and hundreds of thousands of people annually worldwide are left in a chronically debilitated state. Experimental studies of stem cell (SC) therapy of stroke and TBI produced promising results, revealed molecular mechanisms of SC therapeutic effects and led to the first clinical trials. In this chapter, the sources and types of SCs, the experimental data accumulated in preclinical studies and the results and perspectives of clinical trials of SC therapy of stroke and TBI will be reviewed.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal